BlossomHill Therapeutics, Inc. (BLSM)

BlossomHill Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

BlossomHill Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Debt / Equity Ratio	-0.15	-0.17	-0.01
Debt / EBITDA Ratio	-0.31	-0.35	-0.01
Debt / FCF Ratio	-0.40	-0.47	-0.02
Net Debt / Equity Ratio	0.61	0.87	1.37
Net Debt / EBITDA Ratio	1.25	1.80	2.76
Net Debt / FCF Ratio	1.62	2.38	3.16
Quick Ratio	7.17	8.83	14.79
Return on Equity (ROE)	46.73%	45.97%	42.12%
Return on Assets (ROA)	-	-37.16%	-28.75%
Return on Invested Capital (ROIC)	-	-51.74%	-36.40%
Return on Capital Employed (ROCE)	461.68%	-43.42%	-36.40%